Razadyne and Stroke - a phase IV clinical study of FDA data

Summary:

Stroke is reported as a side effect among people who take Razadyne (galantamine hydrobromide), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Aspirin, and have Dementia alzheimer's type.

The phase IV clinical study analyzes which people have Stroke when taking Razadyne. It is created by eHealthMe based on reports of 596 people who have side effects when taking Razadyne from the FDA, and is updated regularly.

What is Razadyne?

Razadyne has active ingredients of galantamine hydrobromide. It is often used in insomnia. eHealthMe is studying from 691 Razadyne users. Check the latest studies of Razadyne.

What is Stroke?

Stroke (sudden death of a portion of the brain cells due to a lack of oxygen) is found to be associated with 2,383 drugs and 3,010 conditions by eHealthMe. Check the latest studies of Stroke.

On Nov, 14, 2025

596 people reported to have side effects when taking Razadyne.
Among them, 29 people (4.87%) have Stroke.

Among these 29 people:

How long have people been on Razadyne when they have Stroke? *

What is the gender of people who have Stroke when taking Razadyne? *

female: 48.28 %
male: 51.72 %

What is the age of people who have Stroke when taking Razadyne? *

What are other drugs people take besides Razadyne? *

What are other side effects people have besides Stroke? *

Fatigue (feeling of tiredness): 15 people, 51.72%
Stress And Anxiety: 13 people, 44.83%
Pain: 13 people, 44.83%
Cataract (clouding of the lens inside the eye): 11 people, 37.93%
Muscle Aches (muscle pain): 10 people, 34.48%
Osteonecrosis Of Jaw (death of bone of jaw): 10 people, 34.48%
Gait Disturbance: 9 people, 31.03%
Nausea (feeling of having an urge to vomit): 9 people, 31.03%
Urinary Tract Infection: 8 people, 27.59%
Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder): 8 people, 27.59%

What are the existing conditions these people have? *

Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 9 people, 31.03%
High Blood Pressure: 5 people, 17.24%
Osteoporosis (bones weak and more likely to break): 3 people, 10.34%
Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 10.34%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 10.34%
Age-Related Macular Degeneration: 2 people, 6.90%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 6.90%
High Blood Cholesterol: 2 people, 6.90%
Chest Pain: 1 person, 3.45%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 3.45%

* Approximation only. Some reports may have incomplete information.

Do you take Razadyne and have Stroke?

- Check whether Stroke is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Razadyne:

Razadyne (691 reports)

Stroke treatments and more:

Stroke (334,631 reports)

Browse all side effects of Razadyne:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Stroke:

Stroke (2,383 drugs)

Browse all the conditions that are associated with Stroke:

Stroke (3,010 conditions)

Drugs similar to Razadyne and Stroke :

How the study uses the data?

The study uses data from the FDA. It is based on galantamine hydrobromide (the active ingredients of Razadyne) and Razadyne (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.